Curcumin Effect on MMPs and TIMPs Genes in a Breast Cancer Cell Line

被引:53
作者
Hassan, Zeinab Korany [1 ,2 ,3 ]
Daghestani, Maha Hassan [1 ,2 ]
机构
[1] King Saud Univ, Ctr Sci Coll, Dept Zool, Riyadh, Saudi Arabia
[2] King Saud Univ, Med Female Coll, Dept Zool, Riyadh, Saudi Arabia
[3] Cairo Univ, Natl Canc Inst, Dept Biol, Cairo, Egypt
关键词
Curcumin; matrix metalloproteinases; tissue inhibitor of metalloproteinases; breast cancer; NF-KAPPA-B; MATRIX-METALLOPROTEINASES; TISSUE INHIBITOR; PROGNOSTIC VALUE; MESSENGER-RNAS; MELANOMA-CELLS; IN-VITRO; EXPRESSION; ANGIOGENESIS; CARCINOMAS;
D O I
10.7314/APJCP.2012.13.7.3259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Curcumin (CM) possesses anti-cancer activity against a variety of tumors. Matrix metalloproteinases (MMPs) play an important role in remodeling the extracellular matrix and their activities are regulated by tissue inhibitor of metalloproteinases (TIMPs) family. Control of MMP and TIMP activity are now of great significance. In this study, the effect of CM is investigated on metastatic MMPs and anti-metastatic TIMPs genes on MDA breast cancer cells cultured in a mixture of DMEM and Ham's F12 medium and treated with different concentrations of CM (10, 20 and 40 mu M for various lengths of time. Reverse transcription followed by quantitative real time PCR was used to detect the gene expression levels of MMPs and TIMPs in CM-treated versus untreated cases and the data were analyzed by one-way ANOVA. At high concentrations of curcumin, TIMP-1, -2, -3 and -4 genes were up-regulated after 48 hours of treatment, their over-expression being accompanied by down-regulation of MMP-2 and MMP-9 gene expression levels in a concentration- and time-dependent manner. These results suggest that curcumin plays a role in regulating cell metastasis by inhibiting MMP-2 and MMP-9 and up-regulating TIMP1 and TIMP4 gene expression in breast cancer cells.
引用
收藏
页码:3259 / 3264
页数:6
相关论文
共 61 条
[1]   RETRACTED: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines (Retracted article. See vol. 102, pg. 147, 2016) [J].
Aggarwal, Bharat B. ;
Banerjee, Sanjeev ;
Bharadwaj, Uddalak ;
Sung, Bokyung ;
Shishodia, Shishir ;
Sethi, Gautam .
BIOCHEMICAL PHARMACOLOGY, 2007, 73 (07) :1024-1032
[2]  
[Anonymous], J SIGNAL TRANSUCT
[3]  
Baker EA, 2002, J CLIN PATHOL-MOL PA, V55, P300
[4]   Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging [J].
Baker, EA ;
Bergin, FG ;
Leaper, DJ .
BRITISH JOURNAL OF SURGERY, 2000, 87 (09) :1215-1221
[5]   Polymorphism (ALA16VAL) correlates with regional lymph node status in breast cancer [J].
Bica, Claudia Giuliano ;
de Moura da Silva, Leonardo Leiria ;
Toscani, Nadima Vieira ;
Zettler, Claudio Galleano ;
do Valle Gottlieb, Maria Gabriela ;
Pereira Alexandre, Claudio Osmar ;
Graudenz, Marcia Silveira ;
Manica da Cruz, Ivana Beatrice .
CANCER GENETICS AND CYTOGENETICS, 2010, 196 (02) :153-158
[6]   Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions:: an in situ hybridization study [J].
Brummer, O ;
Athar, S ;
Riethdorf, L ;
Löning, T ;
Herbst, H .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (06) :566-573
[7]   The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice [J].
Buck, TB ;
Yoshiji, H ;
Harris, SR ;
Bunce, OR ;
Thorgeirsson, UP .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :732-735
[8]  
Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]
[9]   Novel functions of TIMPs in cell signaling [J].
Chirco, R ;
Liu, XW ;
Jung, KK ;
Kim, HRC .
CANCER AND METASTASIS REVIEWS, 2006, 25 (01) :99-113
[10]   Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner [J].
Choudhuri, T ;
Pal, S ;
Das, T ;
Sa, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :20059-20068